Capstone Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Capstone Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	–	–	1967
2022 Q1	$0	Hold	3	–	–	﹤0.01%	2105
2021 Q4	$0	Hold	3	–	–	﹤0.01%	1954
2021 Q3	$0	Hold	3	–	–	﹤0.01%	2031
2021 Q2	$0	Hold	3	–	–	﹤0.01%	1782
2021 Q1	$0	Buy	+3	New	+$477	﹤0.01%	1805
2019 Q3	–	Sell	-3	Closed	–	–	1399
2019 Q2	$0	Buy	+3	New	+$319	﹤0.01%	1411
2015 Q4	–	Sell	-6,003	Closed	-$606K	–	504
2015 Q3	$606K	Buy	+6,003	New	+$720K	0.01%	260
2015 Q1	–	Sell	-3,603	Closed	-$364K	–	302
2014 Q4	$364K	Buy	+3,603	New	+$350K	0.01%	296
2014 Q2	–	Sell	-13,800	Closed	-$1.09M	–	428
2014 Q1	$1.09M	Buy	+13,800	New	+$1.15M	0.01%	291

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capstone Investment Advisors's IBB Position: Q2 2022 in Review

Capstone Investment Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 3 shares.

Capstone Investment Advisors first reported a position in IBB in Q1 2014 and held it in 9 quarters. The position peaked at $1.09M in Q1 2014. 859 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

Capstone Investment Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
Capstone Investment Advisors sold 3 iShares Biotechnology ETF shares in Q2 2022.
Capstone Investment Advisors first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 9 quarters.
Capstone Investment Advisors's iShares Biotechnology ETF position peaked at $1.09M in Q1 2014.
859 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Capstone Investment Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.